Publication 6/01/2009

Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.

Pichla-Gollon SL, Lin SW, Hensley SE, Lasaro MO, Herkenhoff-Haut L, Drinker M, Tatsis N, Gao GP, Wilson JM, Ertl HC, Bergelson JM

Journal Of Virology

Publication 2/01/2007

Structure-based identification of a major neutralizing site in an adenovirus hexon.

Pichla-Gollon SL, Drinker M, Zhou X, Xue F, Rux JJ, Gao GP, Wilson JM, Ertl HC, Burnett RM, Bergelson JM

Journal Of Virology

Publication 4/10/2003

Efficient transduction of human monocyte-derived dendritic cells by chimpanzee-derived adenoviral vector.

Varnavski AN, Schlienger K, Bergelson JM, Gao GP, Wilson JM

Human Gene Therapy

Publication 3/01/2002

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product.

Xiang Z, Gao G, Reyes-Sandoval A, Cohen CJ, Li Y, Bergelson JM, Wilson JM, Ertl HC

Journal Of Virology

Publication 1/01/2002

Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor.

Cohen CJ, Xiang ZQ, Gao GP, Ertl HC, Wilson JM, Bergelson JM

The Journal Of General Virology